Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways

Bibliographic Details
Title: Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways
Authors: Sabrina Manni, Marilena Carrino, Francesco Piazza
Source: Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-10 (2017)
Publisher Information: BMC, 2017.
Publication Year: 2017
Collection: LCC:Diseases of the blood and blood-forming organs
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Multiple myeloma, CK1, CK2, Bone marrow microenvironment, Survival signaling pathways, Non-oncogene addiction, Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Multiple myeloma (MM) is a malignant tumor of transformed plasma cells. MM pathogenesis is a multistep process. This cancer can occur de novo (rarely) or it can develop from monoclonal gammopathy of undetermined significance (most of the cases). MM can be asymptomatic (smoldering myeloma) or clinically active. Malignant plasma cells exploit intrinsic and extrinsic bone marrow microenvironment-derived growth signals. Upregulation of stress-coping pathways is also instrumental to maintain MM cell growth. The phylogenetically related Ser/Thr kinases CSNK1A1 (CK1α) and CSNK2 (CK2) have recently gained a growing importance in hematologic malignancies arising both from precursors and from mature blood cells. In multiple myeloma, CK1α or CK2 sustain oncogenic cascades, such as the PI3K/AKT, JAK/STAT, and NF-κB, as well as propel stress-related signaling that help in coping with different noxae. Data also suggest that these kinases modulate the delivery of growth factors and cytokines from the bone marrow stroma. The “non-oncogene addiction” phenotype generated by the increased activity of CK1α and CK2 in multiple myeloma contributes to malignant plasma cell proliferation and survival and represents an Achilles’ heel for the activity of small ATP competitive CK1α or CK2 inhibitors.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1756-8722
Relation: http://link.springer.com/article/10.1186/s13045-017-0529-5; https://doaj.org/toc/1756-8722
DOI: 10.1186/s13045-017-0529-5
Access URL: https://doaj.org/article/4623a45cba854462b360b98c760810ba
Accession Number: edsdoj.4623a45cba854462b360b98c760810ba
Database: Directory of Open Access Journals
More Details
ISSN:17568722
DOI:10.1186/s13045-017-0529-5
Published in:Journal of Hematology & Oncology
Language:English